Market in Spain is around 26 million patients while the greater London area stands at nine million
Updated Date: Tue, 07 Feb 2023 00:00:00 EST
Phase 3 trial of single-shot chikungunya vaccine candidate unfolds among an adolescent cohort
Benefits were identified with Cabometyx in combination with nivolumab across all efficacy measures
Collaboration continues to be focused on reaching locations where temporary clinics cannot be easily set up
Partnership will focus on essential new therapies across neurodegenerative diseases
Updated Date: Fri, 03 Feb 2023 00:00:00 EST
Updated Date: Fri, 03 Feb 2023 00:00:00 EST
Updated Date: Fri, 03 Feb 2023 00:00:00 EST
